These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8551823)
1. Breast cancer imaging with radiolabelled peptide from complementarity-determining region of antitumour antibody. Sivolapenko GB; Douli V; Pectasides D; Skarlos D; Sirmalis G; Hussain R; Cook J; Courtenay-Luck NS; Merkouri E; Konstantinides K Lancet; 1995 Dec 23-30; 346(8991-8992):1662-6. PubMed ID: 8551823 [TBL] [Abstract][Full Text] [Related]
2. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. Welt S; Divgi CR; Scott AM; Garin-Chesa P; Finn RD; Graham M; Carswell EA; Cohen A; Larson SM; Old LJ J Clin Oncol; 1994 Jun; 12(6):1193-203. PubMed ID: 8201382 [TBL] [Abstract][Full Text] [Related]
3. Structure-function correlation and biostability of antibody CDR-derived peptides as tumour imaging agents. Hussain R; Courtenay-Luck NS; Siligardi G Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):67-70. PubMed ID: 9575342 [TBL] [Abstract][Full Text] [Related]
4. The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast. Williams MR; Perkins AC; Campbell FC; Pimm MV; Hardy JG; Wastie ML; Blamey RW; Baldwin RW Clin Oncol; 1984 Dec; 10(4):375-81. PubMed ID: 6391773 [TBL] [Abstract][Full Text] [Related]
6. Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody. Couto JR; Blank EW; Peterson JA; Ceriani RL Hybridoma; 1993 Feb; 12(1):15-23. PubMed ID: 8454302 [TBL] [Abstract][Full Text] [Related]
7. Immunoscintigraphy for detection of lymph node metastases from breast cancer. Thompson CH; Lichtenstein M; Stacker SA; Leyden MJ; Salehi N; Andrews JT; McKenzie IF Lancet; 1984 Dec; 2(8414):1245-7. PubMed ID: 6150280 [TBL] [Abstract][Full Text] [Related]
8. Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer. Kalofonos HP; Sackier JM; Hatzistylianou M; Pervez S; Taylor-Papadimitriou J; Waxman JH; Lavender JP; Wood C; Epenetos AA Br J Cancer; 1989 Jun; 59(6):939-42. PubMed ID: 2736231 [TBL] [Abstract][Full Text] [Related]
9. Tumour visualisation using a radiolabelled monoclonal antibody. Zalcberg JR; Thompson CH; Lichtenstein M; Leyden MJ; Andrews JT; Sullivan JR; McKenzie IF Aust N Z J Med; 1983 Dec; 13(6):571-7. PubMed ID: 6326726 [TBL] [Abstract][Full Text] [Related]
10. Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines. Rothe A; Klimka A; Tur MK; Pfitzner T; Huhn M; Sasse S; Mallmann P; Engert A; Barth S Int J Mol Med; 2004 Oct; 14(4):729-35. PubMed ID: 15375609 [TBL] [Abstract][Full Text] [Related]
11. The localization of human breast carcinomas by radiolabelled monoclonal antibodies. Rainsbury RM Br J Surg; 1984 Oct; 71(10):805-12. PubMed ID: 6237710 [TBL] [Abstract][Full Text] [Related]
12. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group. Goldenberg DM; Wegener W Acta Med Austriaca; 1997; 24(2):55-9. PubMed ID: 9227788 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of a breast cancer-associated antigen defined by RCC-1 antibody. Tjandra JJ; Zalcberg J; Xing PX; McKenzie IF Immunol Cell Biol; 1990 Jun; 68 ( Pt 3)():191-8. PubMed ID: 1699883 [TBL] [Abstract][Full Text] [Related]
14. Breast tumor radioimmunodetection with a 111In-labeled monoclonal antibody (MA5) against a mucin-like antigen. Major PP; Dion AS; Williams CJ; Mattes MJ; Wang T; Rosenthall L Cancer Res; 1990 Feb; 50(3 Suppl):927s-931s. PubMed ID: 2297743 [TBL] [Abstract][Full Text] [Related]
16. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions. Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077 [TBL] [Abstract][Full Text] [Related]
17. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer. Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690 [TBL] [Abstract][Full Text] [Related]
18. The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study. Tjandra JJ; Sacks NP; Thompson CH; Leyden MJ; Stacker SA; Lichtenstein M; Russell IS; Collins JP; Andrews JT; Pietersz GA Br J Cancer; 1989 Feb; 59(2):296-302. PubMed ID: 2930695 [TBL] [Abstract][Full Text] [Related]
19. Liposomally entrapped second antibody improves tumour imaging with radiolabelled (first) antitumour antibody. Begent RH; Keep PA; Green AJ; Searle F; Bagshawe KD; Jewkes RF; Jones BE; Barratt GM; Ryman BE Lancet; 1982 Oct; 2(8301):739-42. PubMed ID: 6125812 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound. Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]